Related Experiment Video
Updated: Jan 26, 2026

Precise Cellular Ablation Approach for Modeling Acute Kidney Injury in Developing Zebrafish
Published on: June 3, 2017
Drugs in Development for Acute Kidney Injury
Matthew Hulse1, Mitchell H Rosner2
1Divison of Critical Care, Department of Anesthesiology, University of Virginia Health System, Charlottesville, VA, 22908, USA.
Abstract:
The care of patients with acute kidney injury (AKI) has been limited due to the lack of effective therapeutics that can either prevent AKI during high-risk situations or treat AKI once established. A revolution in the scientific understanding of the pathogenesis of AKI has led to the identification of potential therapeutic targets. These targets include pathways involved in inflammation, cellular repair and fibrosis, cellular metabolism and mitochondrial function, oxidative stress, apoptosis, and hemodynamics and oxygen delivery. Many compounds are entering early-phase clinical trials. In addition, efforts to better describe sub-categories of AKI (through endo-phenotyping) hold promise to target therapies more effectively based upon pathways that are operative in the pathogenesis. These advances bring optimism that the care of patients with AKI will be transformed with the hope of better outcomes.
Insights
Effective treatments for acute kidney injury (AKI) are lacking. New research into AKI
Area of Science:
- Nephrology
- Translational Medicine
- Pharmacology
Background:
- Current management of acute kidney injury (AKI) lacks effective preventative or therapeutic options.
- Significant advancements in understanding AKI pathogenesis have revealed numerous potential therapeutic targets.
Purpose of the Study:
- To review the current landscape of therapeutic targets for acute kidney injury (AKI).
- To highlight novel approaches in AKI treatment and patient stratification.
Main Methods:
- Review of scientific literature on AKI pathogenesis and therapeutic targets.
- Analysis of pathways implicated in AKI, including inflammation, fibrosis, metabolism, oxidative stress, apoptosis, and hemodynamics.
- Discussion of early-phase clinical trial compounds and endo-phenotyping strategies.
Main Results:
- Identification of multiple molecular pathways as potential targets for AKI therapeutics.
- Progress in developing novel compounds targeting these pathways, with many in early clinical trials.
- Endo-phenotyping offers a promising approach for personalized AKI therapy.
Conclusions:
- Advances in understanding AKI pathogenesis are paving the way for new treatments.
- Targeted therapies and personalized approaches hold promise for transforming AKI patient care and outcomes.
- Optimism exists for improved clinical outcomes in AKI patients due to ongoing research and development.
Related Concept Videos
Acute Kidney Injury I: Introduction
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury VI: Nursing Management
Acute Kidney Injury V: Interprofessional Care
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention

